Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?
Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are poorly understood autoimmune liver diseases. Immunosuppression is used to treat AIH and ursodeoxycholic acid is used to slow the progression of PBC. Nevertheless, a proportion of patients with both disorders progress to liver failure...
Main Authors: | Andrew L. Mason, Aldo J. Montano-Loza, Shawn T. Wasilenko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/5/2/423 |
Similar Items
-
The pathogenesis of primary biliary cirrhosis Patogénesis en cirrosis biliar primaria
by: J. A. Solís Herruzo, et al.
Published: (2009-06-01) -
Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes
by: Yoonsang Park, et al.
Published: (2015-06-01) -
Current concepts in the pathogenesis of primary biliary cirrhosis
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2005-07-01) -
Primary biliary cirrhosis: Report
by: Filipović Branka, et al.
Published: (2002-01-01) -
Hepatocellular carcinoma in patients with autoimmune liver diseases: Two case reports and literature review
by: Judith Meza-Junco;, et al.
Published: (2007-04-01)